Integrated strategy and banking to support and accelerate the entire healthcare development lifecycle, from early scientific discovery through commercial growth and global expansion.
Pharma | Biotech | Medtech | Diagnostics | Medical Tools
HEALTHCARE STRATEGY AND FINANCING
DNB Carnegie Back Bay Healthcare is a global team of healthcare strategy advisors, investment bankers, and corporate lenders supporting pharma, biopharma, medtech, tools and diagnostics, services, and healthcare investors across various stages and sectors.
We connect the Nordic/EU and US healthcare markets, setting strategies for clinical and commercial development, licensing, partnering, and M&A. We provide guidance and execution for all aspects of financing and investment banking, supporting growth, innovation, and success across the life sciences and healthcare sectors.
The platform combines strategic advisory, investment banking, highly ranked equity research, and institutional sales to give companies visibility and access in the US, the world’s leading healthcare investment market, and the Nordics, one of the most productive healthcare ecosystems in the world.
DNB Carnegie Back Bay Healthcare enables direct engagement with institutional and boutique generalist and specialist investors, senior strategic leaders, and industry partners through curated introductions and targeted outreach.
One Team | Global Reach.
Learn more about DNB Carnegie Back Bay, subscribe for market insights, request an overview of our capabilities, or connect with our advisors.
HEALTHCARE MARKET
NEWS & EVENTS
Title of Press Release
Press release lede
More about our partners:
Analyst Reports
DNB Carnegie Back Bay publishes industry reports on the healthcare sector. Reports are authored by Back Bay Life Science Advisors’ experts on global life science development and DNB’s senior equity analysts.
Read our latest:
10th Annual Nordic American Healthcare Conference Highlights and Key Takeaways
The 10th Annual Nordic American Healthcare Conference in New York City brought together healthcare companies, US healthcare investors, analysts, and industry leaders for two days of presentations and discussions focused on innovation, investment, and the forces shaping the market.
Select Healthcare Transactions
-
DNB Carnegie|Back Bay provides a full, nuanced understanding of the scientific, clinical, commercial, and transactional drivers of company success and shareholder returns. Every engagement is grounded in strategic advice built on decades of experience and informed by rigorous, cross-disciplinary market industry insight.
We deliver solutions for healthcare and life science companies that uniquely blend strategic insight with transactional excellence, integrating domain expertise and precise execution.
Our teams are paired with strategic advisors who approach each transaction with rigorous analysis of therapeutic pathways, regulatory environments, and commercial dynamics.
Demonstrated leadership in anticipating the impact of emerging science on future standards of care
Track record of translating complex innovation into actionable growth strategies
Deep domain expertise leveraged to identify strategic inflection points and unlock value
Proven success in navigating cross-border deals with multi-stakeholder alignment
Strategic consulting capabilities include:
Asset and franchise strategy
Acquisition search, valuation and diligence
Financing, liquidity and partnering strategy
Pricing and market access
Portfolio evaluation and positioning
Competitive intelligence
Platform implementation
Payor/Pricing strategy
Contracting strategy
Launch and counter-launch strategy
Product positioning, branding & messaging
Life-cycle management
Corporate growth strategy
Liquidity and exit planning
Launch, milestone communications and IR support
-
DNB Carnegie | Back Bay is a bridge between global investors and the US and European capital markets.
We drive growth for healthcare companies with our unique ECM platform, with exceptional coverage of both the US and EU healthcare markets and investors.
In addition to US institutional investor access, we align demand from European investors to US IPO and follow-on offerings.
Our ECM teams develop each company’s equity story through extensive primary research and domain knowledge in healthcare and life sciences.
We provide continuous after-market support, including cross-border institutional sales, non-deal roadshows, and presence at our global healthcare conferences in New York, Stockholm, and Oslo.
Our capital markets team specializes in structures that allow healthcare companies to succeed, including:
Initial Public Offerings (IPOs) across US and Nordic exchanges
Follow-on Offerings
Private Placements
Convertible Bonds
At-Market Transactions
Convertible Debt
Term Loan Debt Facilities
» Read our latest ECM perspectives
» Subscribe to our weekly ECM updates -
DNB Carnegie is the Nordic region's leading investment bank. Now, together with Back Bay Life Science Advisors, DNB Carnegie|Back Bay Healthcare provides a leading edge to global healthcare companies across US and global markets, delivering financing and strategic transactional execution with discipline and scale.
Our debt and equity capital markets platform brings significant placing power, a proven ability to generate investor demand, and a differentiated sales force with deep healthcare and life sciences relationships.
-
Our healthcare research team is globally recognized, award-winning, and provides differentiated equity research distribution and industry coverage.
DNB Carnegie research is the leading equity research group in the Nordics, with coverage spanning multiple sectors and technologies, reaching from the Nordics to the United States.
-
DNB Carnegie|Back Bay Healthcare sales force covers top-tier US and EU investors, connecting innovation, capital, and strategy across borders.
-
Complementing our capital markets capabilities, our global corporate banking platform and $300B balance sheet provide tailored financing solutions, including acquisition financing, loan origination, and treasury support. With strong structuring expertise, substantial underwriting capacity, and efficient execution, we serve as a long-term financial partner supporting growth, strategic transactions, and capital optimization.
DNB Carnegie|Back Bay is a subsidiary of DNB Bank, which provides the financial underpinning of a top-ranked bank with a unique footprint in the Nordic and US markets.
-
Our global healthcare team produces several industry forums providing clients and covered companies the opportunity to connect with key healthcare investors across the US and EU markets, including our healthcare investor conferences held in Stockholm, Oslo and New York City.
» Inquire
-
Our US healthcare equity conference unites large and mid-cap public and private IPO-ready US and Nordic healthcare and life science companies with US institutional investors. DNB Carnegie | Back Bay identifies leading biopharma, pharma, medtech, and healthtech companies for presentations, 1:1 meetings, and networking opportunities with leading institutional and specialist investors.
-
Our strategic and transaction advisory practice, combined with the expertise of healthcare and equity analysts, provides unparalleled insight into market deal flow, therapeutic area development and critical solutions for growth and success.